SAMJIN PHARMACEUTICAL CO.,LTD Q3 operating profit KRW 11.9 billion, up 22.0% from a year earlier
AI summary · Not investment advice
Samjin Pharmaceutical sold KRW 84.1 billion in Q3 and made KRW 11.9 billion from its main business, up 22.0% from a year earlier and up 66.8% from the previous quarter.
Operating profit · 3 months
KRW 11.9 billion
Key facts
- Revenue (3 months)
- KRW 84.1 billion
- Net income (3 months)
- KRW 8.2 billion
- Period
- Q3 (cumulative 2026.01.01 ~ 2026.09.30)
- Revenue (prior-year 3 months)
- KRW 83.1 billion
- Revenue (year to date)
- KRW 231.8 billion
- Operating profit (prior-year 3 months)
- KRW 9.8 billion
- Operating profit (year to date)
- KRW 22.7 billion
- Net income (prior-year 3 months)
- KRW 6.8 billion
- Net income (year to date)
- KRW 15.7 billion
Commentary
AI commentary · Not investment advice
What happened
Samjin Pharmaceutical filed its quarterly report for the third quarter of 2026, on a standalone basis. Sales for the 3 months were KRW 84.07 billion, up 1.1% from the same period a year earlier. They rose 5.6% from the previous quarter.
In the company's terms
Operating profit (profit from the core business) for the 3 months was KRW 11.93 billion. That is up 22.0% from a year earlier and up 66.8% from the previous quarter. Net income (final profit after taxes and all other costs) for the 3 months was KRW 8.16 billion. That is up 19.3% from a year earlier and up 33.8% from the previous quarter.
What changes for shareholders
For the year to date, sales were KRW 231.78 billion. Operating profit was KRW 22.67 billion. Net income was KRW 15.65 billion.
Comments
No comments yet
Comments from shareholders will appear here.
Ad
Verify your holdings and catch the next disclosure
Verify the stocks you hold and get new disclosures as app alerts.

App design sample
Get the next disclosure as an app alert
Get app alerts for new disclosures and stake changes on your watchlist
S